Share-based Payment Arrangement, Expense of BIOMARIN PHARMACEUTICAL INC from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BIOMARIN PHARMACEUTICAL INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • BIOMARIN PHARMACEUTICAL INC Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $49,265,000, a 13% increase year-over-year.
  • BIOMARIN PHARMACEUTICAL INC Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $186,415,000, a 8.8% decline year-over-year.
  • BIOMARIN PHARMACEUTICAL INC annual Share-based Payment Arrangement, Expense for 2024 was $201,571,000, a 2.7% decline from 2023.
  • BIOMARIN PHARMACEUTICAL INC annual Share-based Payment Arrangement, Expense for 2023 was $207,099,000, a 5.5% increase from 2022.
  • BIOMARIN PHARMACEUTICAL INC annual Share-based Payment Arrangement, Expense for 2022 was $196,308,000, a 0.48% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

BIOMARIN PHARMACEUTICAL INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $186,415,000 $49,265,000 +$5,776,000 +13% 01 Jul 2025 30 Sep 2025 10-Q 28 Oct 2025 2025 Q3
Q2 2025 $180,639,000 $47,531,000 -$383,000 -0.8% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $181,022,000 $37,700,000 -$20,549,000 -35% 01 Jan 2025 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q4 2024 $201,571,000 $51,919,000 -$2,936,000 -5.4% 01 Oct 2024 31 Dec 2024 10-K 24 Feb 2025 2024 FY
Q3 2024 $204,507,000 $43,489,000 -$4,898,000 -10% 01 Jul 2024 30 Sep 2024 10-Q 28 Oct 2025 2025 Q3
Q2 2024 $209,405,000 $47,914,000 -$2,248,000 -4.5% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025 2025 Q2
Q1 2024 $211,653,000 $58,249,000 +$4,554,000 +8.5% 01 Jan 2024 31 Mar 2024 10-Q 02 May 2025 2025 Q1
Q4 2023 $207,099,000 $54,855,000 +$8,121,000 +17% 01 Oct 2023 31 Dec 2023 10-K 24 Feb 2025 2024 FY
Q3 2023 $198,978,000 $48,387,000 -$6,276,000 -11% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024 2024 Q3
Q2 2023 $205,254,000 $50,162,000 +$3,084,000 +6.6% 01 Apr 2023 30 Jun 2023 10-Q 05 Aug 2024 2024 Q2
Q1 2023 $202,170,000 $53,695,000 +$5,862,000 +12% 01 Jan 2023 31 Mar 2023 10-Q 26 Apr 2024 2024 Q1
Q4 2022 $196,308,000 $46,734,000 +$2,843,000 +6.5% 01 Oct 2022 31 Dec 2022 10-K 24 Feb 2025 2024 FY
Q3 2022 $193,465,000 $54,663,000 +$5,637,000 +11% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 $187,828,000 $47,078,000 -$7,765,000 -14% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023 2023 Q2
Q1 2022 $195,593,000 $47,833,000 -$1,670,000 -3.4% 01 Jan 2022 31 Mar 2022 10-Q 28 Apr 2023 2023 Q1
Q4 2021 $197,263,000 $43,891,000 -$3,695,000 -7.8% 01 Oct 2021 31 Dec 2021 10-K 26 Feb 2024 2023 FY
Q3 2021 $200,958,000 $49,026,000 -$1,143,000 -2.3% 01 Jul 2021 30 Sep 2021 10-Q 28 Oct 2022 2022 Q3
Q2 2021 $202,101,000 $54,843,000 +$9,881,000 +22% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 $192,220,000 $49,503,000 +$2,509,000 +5.3% 01 Jan 2021 31 Mar 2021 10-Q 29 Apr 2022 2022 Q1
Q4 2020 $189,711,000 $47,586,000 +$9,484,000 +25% 01 Oct 2020 31 Dec 2020 10-K 27 Feb 2023 2022 FY
Q3 2020 $180,227,000 $50,169,000 +$10,996,000 +28% 01 Jul 2020 30 Sep 2020 10-Q 29 Oct 2021 2021 Q3
Q2 2020 $169,231,000 $44,962,000 +$5,133,000 +13% 01 Apr 2020 30 Jun 2020 10-Q 30 Jul 2021 2021 Q2
Q1 2020 $164,098,000 $46,994,000 +$4,233,000 +9.9% 01 Jan 2020 31 Mar 2020 10-Q 30 Apr 2021 2021 Q1
Q4 2019 $159,865,000 $38,102,000 +$1,543,000 +4.2% 01 Oct 2019 31 Dec 2019 10-K 25 Feb 2022 2021 FY
Q3 2019 $158,322,000 $39,173,000 +$2,127,000 +5.7% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020 2020 Q3
Q2 2019 $156,195,000 $39,829,000 +$1,223,000 +3.2% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020 2020 Q2
Q1 2019 $154,972,000 $42,761,000 +$6,153,000 +17% 01 Jan 2019 31 Mar 2019 10-Q 01 May 2020 2020 Q1
Q4 2018 $148,819,000 $36,559,000 +$2,974,000 +8.9% 01 Oct 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
Q3 2018 $145,845,000 $37,046,000 +$1,143,000 +3.2% 01 Jul 2018 30 Sep 2018 10-Q/A 04 Nov 2019 2019 Q3
Q2 2018 $144,702,000 $38,606,000 -$1,495,000 -3.7% 01 Apr 2018 30 Jun 2018 10-Q 02 Aug 2019 2019 Q2
Q1 2018 $146,197,000 $36,608,000 +$5,934,000 +19% 01 Jan 2018 31 Mar 2018 10-Q 29 Apr 2019 2019 Q1
Q4 2017 $140,263,000 $33,585,000 -$4,079,000 -11% 01 Oct 2017 31 Dec 2017 10-K 27 Feb 2020 2019 FY
Q3 2017 $144,342,000 $35,903,000 +$3,001,000 +9.1% 01 Jul 2017 30 Sep 2017 10-Q 26 Oct 2018 2018 Q3
Q2 2017 $141,341,000 $40,101,000 +$6,203,000 +18% 01 Apr 2017 30 Jun 2017 10-Q 03 Aug 2018 2018 Q2
Q1 2017 $135,138,000 $30,674,000 +$497,000 +1.6% 01 Jan 2017 31 Mar 2017 10-Q 27 Apr 2018 2018 Q1
Q4 2016 $134,641,000 $37,664,000 +$7,098,000 +23% 01 Oct 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
Q3 2016 $127,543,000 $32,902,000 +$4,144,000 +14% 01 Jul 2016 30 Sep 2016 10-Q 31 Oct 2017 2017 Q3
Q2 2016 $123,399,000 $33,898,000 +$4,389,000 +15% 01 Apr 2016 30 Jun 2016 10-Q 02 Aug 2017 2017 Q2
Q1 2016 $119,010,000 $30,177,000 +$7,485,000 +33% 01 Jan 2016 31 Mar 2016 10-Q 04 May 2017 2017 Q1
Q4 2015 $111,525,000 $30,566,000 -$2,286,000 -7% 01 Oct 2015 31 Dec 2015 10-K 26 Feb 2018 2017 FY
Q3 2015 $113,811,000 $28,758,000 +$8,754,000 +44% 01 Jul 2015 30 Sep 2015 10-Q 03 Nov 2016 2016 Q3
Q2 2015 $105,057,000 $29,509,000 +$12,259,000 +71% 01 Apr 2015 30 Jun 2015 10-Q 08 Aug 2016 2016 Q2
Q1 2015 $92,798,000 $22,692,000 +$6,388,000 +39% 01 Jan 2015 31 Mar 2015 10-Q 02 May 2016 2016 Q1
Q4 2014 $86,410,000 $32,852,000 +$10,175,000 +45% 01 Oct 2014 31 Dec 2014 10-K 27 Feb 2017 2016 FY
Q3 2014 $76,235,000 $20,004,000 +$3,799,000 +23% 01 Jul 2014 30 Sep 2014 10-Q 02 Nov 2015 2015 Q3
Q2 2014 $72,436,000 $17,250,000 +$3,321,000 +24% 01 Apr 2014 30 Jun 2014 10-Q 05 Aug 2015 2015 Q2
Q1 2014 $69,115,000 $16,304,000 +$4,739,000 +41% 01 Jan 2014 31 Mar 2014 10-Q 05 May 2015 2015 Q1
Q4 2013 $64,376,000 $22,677,000 +$10,615,000 +88% 01 Oct 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
Q3 2013 $53,761,000 $16,205,000 +$4,066,000 +33% 01 Jul 2013 30 Sep 2013 10-Q 28 Oct 2014 2014 Q3
Q2 2013 $49,695,000 $13,929,000 +$1,292,000 +10% 01 Apr 2013 30 Jun 2013 10-Q 31 Jul 2014 2014 Q2
Q1 2013 $48,403,000 $11,565,000 +$431,000 +3.9% 01 Jan 2013 31 Mar 2013 10-Q 02 May 2014 2014 Q1
Q4 2012 $47,972,000 $12,062,000 +$848,000 +7.6% 01 Oct 2012 31 Dec 2012 10-K 02 Mar 2015 2014 FY
Q3 2012 $47,124,000 $12,139,000 +$521,000 +4.5% 01 Jul 2012 30 Sep 2012 10-Q 28 Oct 2013 2013 Q3
Q2 2012 $46,603,000 $12,637,000 +$2,030,000 +19% 01 Apr 2012 30 Jun 2012 10-Q 29 Jul 2013 2013 Q2
Q1 2012 $44,573,000 $11,134,000 +$754,000 +7.3% 01 Jan 2012 31 Mar 2012 10-Q 29 Apr 2013 2013 Q1
Q4 2011 $43,819,000 $11,214,000 01 Oct 2011 31 Dec 2011 10-K 26 Feb 2014 2013 FY
Q3 2011 $11,618,000 +$1,661,000 +17% 01 Jul 2011 30 Sep 2011 10-Q 29 Oct 2012 2012 Q3
Q2 2011 $10,607,000 +$1,441,000 +16% 01 Apr 2011 30 Jun 2011 10-Q 02 Aug 2012 2012 Q2
Q1 2011 $10,380,000 01 Jan 2011 31 Mar 2011 10-Q 30 Apr 2012 2012 Q1
Q3 2010 $9,957,000 01 Jul 2010 30 Sep 2010 10-Q 31 Oct 2011 2011 Q3
Q2 2010 $9,166,000 01 Apr 2010 30 Jun 2010 10-Q 01 Aug 2011 2011 Q2

BIOMARIN PHARMACEUTICAL INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $201,571,000 -$5,528,000 -2.7% 01 Jan 2024 31 Dec 2024 10-K 24 Feb 2025 2024 FY
2023 $207,099,000 +$10,791,000 +5.5% 01 Jan 2023 31 Dec 2023 10-K 24 Feb 2025 2024 FY
2022 $196,308,000 -$955,000 -0.48% 01 Jan 2022 31 Dec 2022 10-K 24 Feb 2025 2024 FY
2021 $197,263,000 +$7,552,000 +4% 01 Jan 2021 31 Dec 2021 10-K 26 Feb 2024 2023 FY
2020 $189,711,000 +$29,846,000 +19% 01 Jan 2020 31 Dec 2020 10-K 27 Feb 2023 2022 FY
2019 $159,865,000 +$11,046,000 +7.4% 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2022 2021 FY
2018 $148,819,000 +$8,556,000 +6.1% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
2017 $140,263,000 +$5,622,000 +4.2% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020 2019 FY
2016 $134,641,000 +$23,116,000 +21% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
2015 $111,525,000 +$25,115,000 +29% 01 Jan 2015 31 Dec 2015 10-K 26 Feb 2018 2017 FY
2014 $86,410,000 +$22,034,000 +34% 01 Jan 2014 31 Dec 2014 10-K 27 Feb 2017 2016 FY
2013 $64,376,000 +$16,404,000 +34% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 $47,972,000 +$4,153,000 +9.5% 01 Jan 2012 31 Dec 2012 10-K 02 Mar 2015 2014 FY
2011 $43,819,000 +$6,327,000 +17% 01 Jan 2011 31 Dec 2011 10-K 26 Feb 2014 2013 FY
2010 $37,492,000 01 Jan 2010 31 Dec 2010 10-K 26 Feb 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.